![]() |
|
|
Vol. 293, Issue 2, 545-550, May 2000
Department of Pharmaceutics, School of Pharmacy, University of
Buffalo, Buffalo, New York
Excessive production of nitric oxide (NO) in the central nervous system
is suspected to contribute to neurodegenerative diseases. Previous
studies showed that excessive central nervous system NO increased the
permeability of the blood-brain barrier (BBB) during experimental
meningitis. The present work hypothesizes that the various NO redox
forms (NO·, NO+, NO
) differentially
mediate disruption of the BBB. Pharmacological agents that release NO
redox forms (i.e., NO prodrugs) were selected based on the rate of NO
release and the liberated NO redox form. An in situ rodent brain
perfusion preparation was used to administer NO prodrugs into the
cerebrovascular circulation, followed by brain perfusion with
[14C]sucrose, a marker of BBB integrity.
Cerebrovasculature infusion of certain NO prodrugs caused a
significant, 2- to 5-fold BBB permeability increase in all forebrain
regions (P < .01). The NO prodrug rank order of
BBB disruption was
S-nitroso-N-acetylpenicillamine-
-cyclodextrin (releases NO·, NO+, and NO
) > Angeli's salt (NO·, NO
) > MAHMA
NONOate ~ diethylamine NONOate (NO·) > spermine
NONOate (NO·) > DETA NONOate ~ Piloty's
acid (negligible NO redox release) ~ saline. When normalized to
BBB disruption caused by hyperosmotic mannitol (100%),
S-nitroso-N-acetylpenicillamine-
-cyclodextrin (NO·, NO+, and NO
) elicited ~45%
disruption, Angeli's salt (NO·, NO
) elicited
~18% disruption, and the NONOates (NO·) ranged from ~0 to
8% disruption. Cerebral blood flows and intracranial pressures were
within normal limits for each tested NO prodrug, thereby suggesting
that BBB disruption was not secondary to altered cerebral perfusion.
Collectively, the results of this work identify that NO· alone
exerts modest BBB disruption compared with the specie combination of
NO· and NO
, and the greatest disruption is exerted
by the combination of NO·, NO
, and
NO+.
This article has been cited by other articles:
![]() |
S. R. Parathath, I. Gravanis, and S. E. Tsirka Nitric Oxide Synthase Isoforms Undertake Unique Roles During Excitotoxicity Stroke, June 1, 2007; 38(6): 1938 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Brown, K. S. Mark, R. D. Egleton, and T. P. Davis Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1045 - C1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Minagar and J S. Alexander Blood-brain barrier disruption in multiple sclerosis Multiple Sclerosis, December 1, 2003; 9(6): 540 - 549. [Abstract] [PDF] |
||||
![]() |
K. M. K. Boje, D. Jaworowicz Jr., and J. J. Raybon Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 319 - 325. [Abstract] [Full Text] [PDF] |
||||